CRSP · CRISPR Therapeutics AG
Market Cap
$5.58B
Shares
96.69M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-13 | 394 | $53.99 | $21,272 |
| 2026-08-11 | 182 | $53.51 | $9,739 |
| 2026-08-10 | 1,449 | $53.52 | $77,550 |
| 2026-08-03 | 5,640 | $47.99 | $270,664 |
| 2026-07-31 | 1,685 | $48.44 | $81,621 |
| 2026-07-30 | 16,844 | $47.64 | $802,448 |
| 2026-07-28 | 724 | $46.73 | $33,833 |
| 2026-07-23 | 203 | $47.24 | $9,590 |
| 2026-07-22 | 303 | $48.15 | $14,589 |
| 2026-07-21 | 802 | $46.99 | $37,686 |
| 2026-07-20 | 3,952 | $47.78 | $188,827 |
| 2026-07-15 | 693 | $50.46 | $34,969 |
| 2026-07-13 | 467,710 | $53.35 | $24,952,329 |
| 2026-07-10 | 4,359 | $56.34 | $245,586 |
| 2026-07-08 | 539 | $60.77 | $32,755 |
| 2026-07-07 | 54,066 | $61.89 | $3,346,145 |
| 2026-07-06 | 400 | $60.08 | $24,032 |
| 2026-07-01 | 65 | $54.54 | $3,545 |
| 2026-06-29 | 584 | $54.92 | $32,073 |
| 2026-06-25 | 20,975 | $53.55 | $1,123,211 |
| 2026-06-23 | 7,844 | $54.36 | $426,400 |
| 2026-06-22 | 5,604 | $54.09 | $303,120 |
| 2026-06-17 | 35 | $52.02 | $1,821 |
| 2026-06-16 | 46 | $52.61 | $2,420 |
| 2026-06-15 | 516,074 | $49.80 | $25,700,485 |
| 2026-06-11 | 85,766 | $49.44 | $4,240,271 |
| 2026-06-09 | 2,506 | $51.60 | $129,310 |
| 2026-06-05 | 1,738 | $56.95 | $98,979 |
| 2026-06-03 | 3,823 | $52.02 | $198,872 |
| 2026-06-02 | 2,517 | $54.19 | $136,396 |
| 2026-06-01 | 900 | $56.18 | $50,562 |
Showing 1–31 of 31 settlements
Key facts
CIK
1674416
CUSIP
H17182108
13F (30d)
385 filings
362 filers
Visit website
Investor relations